ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $203,000 | +0.5% | 7,741 | -2.8% | 0.00% | 0.0% |
| Q2 2022 | $202,000 | -17.6% | 7,963 | +2.7% | 0.00% | 0.0% |
| Q1 2022 | $245,000 | -53.3% | 7,753 | -40.2% | 0.00% | -50.0% |
| Q4 2021 | $525,000 | -0.2% | 12,974 | -13.9% | 0.00% | 0.0% |
| Q3 2021 | $526,000 | -12.3% | 15,071 | -31.1% | 0.00% | -20.0% |
| Q2 2021 | $600,000 | -7.4% | 21,863 | -5.3% | 0.01% | -16.7% |
| Q1 2021 | $648,000 | +20.7% | 23,091 | +11.7% | 0.01% | 0.0% |
| Q4 2020 | $537,000 | +38.8% | 20,675 | -8.5% | 0.01% | +20.0% |
| Q3 2020 | $387,000 | -3.2% | 22,600 | +39.9% | 0.01% | 0.0% |
| Q2 2020 | $400,000 | -20.0% | 16,153 | -55.1% | 0.01% | -44.4% |
| Q1 2020 | $500,000 | +19.9% | 36,015 | -12.7% | 0.01% | +50.0% |
| Q4 2019 | $417,000 | +26.0% | 41,240 | +13.5% | 0.01% | +20.0% |
| Q3 2019 | $331,000 | -7.3% | 36,347 | -19.1% | 0.01% | 0.0% |
| Q2 2019 | $357,000 | -44.4% | 44,946 | -12.6% | 0.01% | -50.0% |
| Q1 2019 | $642,000 | +20.0% | 51,410 | +3.4% | 0.01% | 0.0% |
| Q4 2018 | $535,000 | -25.7% | 49,698 | -3.8% | 0.01% | -16.7% |
| Q3 2018 | $720,000 | +251.2% | 51,660 | +208.6% | 0.01% | +200.0% |
| Q2 2018 | $205,000 | – | 16,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |